CRISPR/Cas9 Market Report

Global CRISPR/Cas9 Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 25, 2021
  • PAGES：169
  • REPORT CODE：GMM652754
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.  Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.

    The CRISPR/Cas9 is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global CRISPR/Cas9 market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the CRISPR/Cas9 industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global CRISPR/Cas9 Market Segmentations:

    By Players:

    • Caribou Biosciences

    • Merck

    • Synthego

    • Cellecta

    • Mirus Bio

    • CRISPR Therapeutics

    • GenScript

    • Takara Bio

    • GeneCopoeia

    • Intellia Therapeutics

    • Horizon Discovery Group

    • Agilent Technologies

    • Thermo Fisher Scientific

    • Editas Medicine

    • Integrated DNA Technologies (IDT)

    By Types:

    • Genome Editing

    • Genetic engineering

    • gRNA Database/Gene Librar

    • CRISPR Plasmid

    • Human Stem Cells

    • Genetically Modified Organisms/Crops

    • Cell Line Engineering

    By End-User:

    • Biotechnology Companies

    • Pharmaceutical Companies

    • Academic Institutes

    • Research and Development Institutes

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of CRISPR/Cas9 Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global CRISPR/Cas9 Market Size and Growth Rate of Genome Editing from 2014 to 2026

      • 1.3.2 Global CRISPR/Cas9 Market Size and Growth Rate of Genetic engineering from 2014 to 2026

      • 1.3.3 Global CRISPR/Cas9 Market Size and Growth Rate of gRNA Database/Gene Librar from 2014 to 2026

      • 1.3.4 Global CRISPR/Cas9 Market Size and Growth Rate of CRISPR Plasmid from 2014 to 2026

      • 1.3.5 Global CRISPR/Cas9 Market Size and Growth Rate of Human Stem Cells from 2014 to 2026

      • 1.3.6 Global CRISPR/Cas9 Market Size and Growth Rate of Genetically Modified Organisms/Crops from 2014 to 2026

      • 1.3.7 Global CRISPR/Cas9 Market Size and Growth Rate of Cell Line Engineering from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global CRISPR/Cas9 Market Size and Growth Rate of Biotechnology Companies from 2014 to 2026

      • 1.4.2 Global CRISPR/Cas9 Market Size and Growth Rate of Pharmaceutical Companies from 2014 to 2026

      • 1.4.3 Global CRISPR/Cas9 Market Size and Growth Rate of Academic Institutes from 2014 to 2026

      • 1.4.4 Global CRISPR/Cas9 Market Size and Growth Rate of Research and Development Institutes from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina CRISPR/Cas9 Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of CRISPR/Cas9 Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of CRISPR/Cas9 by Major Types

      • 3.4.1 CRISPR/Cas9 Market Size and Growth Rate of Genome Editing

      • 3.4.2 CRISPR/Cas9 Market Size and Growth Rate of Genetic engineering

      • 3.4.3 CRISPR/Cas9 Market Size and Growth Rate of gRNA Database/Gene Librar

      • 3.4.4 CRISPR/Cas9 Market Size and Growth Rate of CRISPR Plasmid

      • 3.4.5 CRISPR/Cas9 Market Size and Growth Rate of Human Stem Cells

      • 3.4.6 CRISPR/Cas9 Market Size and Growth Rate of Genetically Modified Organisms/Crops

      • 3.4.7 CRISPR/Cas9 Market Size and Growth Rate of Cell Line Engineering

    4 Segmentation of CRISPR/Cas9 Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of CRISPR/Cas9 by Major End-Users

      • 4.4.1 Market Size and Growth Rate of CRISPR/Cas9 in Biotechnology Companies

      • 4.4.2 Market Size and Growth Rate of CRISPR/Cas9 in Pharmaceutical Companies

      • 4.4.3 Market Size and Growth Rate of CRISPR/Cas9 in Academic Institutes

      • 4.4.4 Market Size and Growth Rate of CRISPR/Cas9 in Research and Development Institutes

    5 Market Analysis by Major Regions

    • 5.1 Global CRISPR/Cas9 Production Analysis by Major Regions

    • 5.2 Global CRISPR/Cas9 Consumption Analysis by Major Regions

    • 5.3 Global CRISPR/Cas9 Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America CRISPR/Cas9 Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe CRISPR/Cas9 Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific CRISPR/Cas9 Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa CRISPR/Cas9 Production, Import, Consumption and Export Analysis

    6 Product Commodity of CRISPR/Cas9 Market in Major Countries

    • 6.1 Top 5 Export Countries in CRISPR/Cas9 market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in CRISPR/Cas9 market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in CRISPR/Cas9 market from 2014 to 2019

    • 6.2 Top 5 Import Countries in CRISPR/Cas9 market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in CRISPR/Cas9 market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in CRISPR/Cas9 market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America CRISPR/Cas9 Landscape Analysis

    • 7.1 North America CRISPR/Cas9 Landscape Analysis by Major Types

    • 7.2 North America CRISPR/Cas9 Landscape Analysis by Major End-Users

    • 7.3 North America CRISPR/Cas9 Landscape Analysis by Major Countries

      • 7.3.1 United States CRISPR/Cas9 Market Volume and Growth Rate

      • 7.3.2 Canada CRISPR/Cas9 Market Volume and Growth Rate

      • 7.3.3 Mexico CRISPR/Cas9 Market Volume and Growth Rate

    8 Europe CRISPR/Cas9 Landscape Analysis

    • 8.1 Europe CRISPR/Cas9 Landscape Analysis by Major Types

    • 8.2 Europe CRISPR/Cas9 Landscape Analysis by Major End-Users

    • 8.3 Europe CRISPR/Cas9 Landscape Analysis by Major Countries

      • 8.3.1 Germany CRISPR/Cas9 Market Volume and Growth Rate

      • 8.3.2 UK CRISPR/Cas9 Market Volume and Growth Rate

      • 8.3.3 France CRISPR/Cas9 Market Volume and Growth Rate

      • 8.3.4 Italy CRISPR/Cas9 Market Volume and Growth Rate

      • 8.3.5 Nordic Countries CRISPR/Cas9 Market Volume and Growth Rate

      • 8.3.6 Spain CRISPR/Cas9 Market Volume and Growth Rate

      • 8.3.7 Belgium CRISPR/Cas9 Market Volume and Growth Rate

      • 8.3.8 Poland CRISPR/Cas9 Market Volume and Growth Rate

      • 8.3.9 Russia CRISPR/Cas9 Market Volume and Growth Rate

      • 8.3.10 Turkey CRISPR/Cas9 Market Volume and Growth Rate

    9 Asia Pacific CRISPR/Cas9 Landscape Analysis

    • 9.1 Asia Pacific CRISPR/Cas9 Landscape Analysis by Major Types

    • 9.2 Asia Pacific CRISPR/Cas9 Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific CRISPR/Cas9 Landscape Analysis by Major Countries

      • 9.3.1 China CRISPR/Cas9 Market Volume and Growth Rate

      • 9.3.2 Japan CRISPR/Cas9 Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand CRISPR/Cas9 Market Volume and Growth Rate

      • 9.3.4 India CRISPR/Cas9 Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries CRISPR/Cas9 Market Volume and Growth Rate

      • 9.3.6 South Korea CRISPR/Cas9 Market Volume and Growth Rate

    10 Latin America, Middle East & Africa CRISPR/Cas9 Landscape Analysis

    • 10.1 Latin America, Middle East & Africa CRISPR/Cas9 Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa CRISPR/Cas9 Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa CRISPR/Cas9 Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries CRISPR/Cas9 Market Volume and Growth Rate

      • 10.3.2 Brazil CRISPR/Cas9 Market Volume and Growth Rate

      • 10.3.3 Nigeria CRISPR/Cas9 Market Volume and Growth Rate

      • 10.3.4 South Africa CRISPR/Cas9 Market Volume and Growth Rate 

      • 10.3.5 Argentina CRISPR/Cas9 Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Caribou Biosciences

      • 11.1.1 Caribou Biosciences Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Merck

      • 11.2.1 Merck Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Synthego

      • 11.3.1 Synthego Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Cellecta

      • 11.4.1 Cellecta Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Mirus Bio

      • 11.5.1 Mirus Bio Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 CRISPR Therapeutics

      • 11.6.1 CRISPR Therapeutics Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 GenScript

      • 11.7.1 GenScript Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Takara Bio

      • 11.8.1 Takara Bio Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 GeneCopoeia

      • 11.9.1 GeneCopoeia Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Intellia Therapeutics

      • 11.10.1 Intellia Therapeutics Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Horizon Discovery Group

      • 11.11.1 Horizon Discovery Group Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Agilent Technologies

      • 11.12.1 Agilent Technologies Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Thermo Fisher Scientific

      • 11.13.1 Thermo Fisher Scientific Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Editas Medicine

      • 11.14.1 Editas Medicine Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Integrated DNA Technologies (IDT)

      • 11.15.1 Integrated DNA Technologies (IDT) Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 85 Figures and 196 Tables)

    • Figure Product Picture

    • Figure CRISPR/Cas9 Market Size and Growth Rate of Genome Editing from 2014 to 2026

    • Figure CRISPR/Cas9 Market Size and Growth Rate of Genetic engineering from 2014 to 2026

    • Figure CRISPR/Cas9 Market Size and Growth Rate of gRNA Database/Gene Librar from 2014 to 2026

    • Figure CRISPR/Cas9 Market Size and Growth Rate of CRISPR Plasmid from 2014 to 2026

    • Figure CRISPR/Cas9 Market Size and Growth Rate of Human Stem Cells from 2014 to 2026

    • Figure CRISPR/Cas9 Market Size and Growth Rate of Genetically Modified Organisms/Crops from 2014 to 2026

    • Figure CRISPR/Cas9 Market Size and Growth Rate of Cell Line Engineering from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Biotechnology Companies from 2014 to 2026

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Pharmaceutical Companies from 2014 to 2026

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Academic Institutes from 2014 to 2026

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Research and Development Institutes from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina CRISPR/Cas9 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of CRISPR/Cas9 Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of CRISPR/Cas9

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of CRISPR/Cas9 by Different Types from 2014 to 2026

    • Table Consumption Share of CRISPR/Cas9 by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Genome Editing

    • Figure Market Size and Growth Rate of Genetic engineering

    • Figure Market Size and Growth Rate of gRNA Database/Gene Librar

    • Figure Market Size and Growth Rate of CRISPR Plasmid

    • Figure Market Size and Growth Rate of Human Stem Cells

    • Figure Market Size and Growth Rate of Genetically Modified Organisms/Crops

    • Figure Market Size and Growth Rate of Cell Line Engineering

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of CRISPR/Cas9 by Different End-Users from 2014 to 2026

    • Table Consumption Share of CRISPR/Cas9 by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Biotechnology Companies

    • Figure Market Size and Growth Rate of Pharmaceutical Companies

    • Figure Market Size and Growth Rate of Academic Institutes

    • Figure Market Size and Growth Rate of Research and Development Institutes

    • Table Global CRISPR/Cas9 Production by Major Regions

    • Table Global CRISPR/Cas9 Production Share by Major Regions

    • Figure Global CRISPR/Cas9 Production Share by Major Regions in 2014

    • Figure Global CRISPR/Cas9 Production Share by Major Regions in 2018

    • Figure Global CRISPR/Cas9 Production Share by Major Regions in 2026

    • Table Global CRISPR/Cas9 Consumption by Major Regions

    • Table Global CRISPR/Cas9 Consumption Share by Major Regions

    • Figure Global CRISPR/Cas9 Consumption Share by Major Regions in 2014

    • Figure Global CRISPR/Cas9 Consumption Share by Major Regions in 2018

    • Figure Global CRISPR/Cas9 Consumption Share by Major Regions in 2026

    • Table North America CRISPR/Cas9 Production, Import, Consumption and Export Analysis

    • Table Europe CRISPR/Cas9 Production, Import, Consumption and Export Analysis

    • Table Asia Pacific CRISPR/Cas9 Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa CRISPR/Cas9 Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in CRISPR/Cas9 market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in CRISPR/Cas9 market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in CRISPR/Cas9 market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in CRISPR/Cas9 market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America CRISPR/Cas9 Consumption by Types from 2014 to 2026

    • Table North America CRISPR/Cas9 Consumption Share by Types from 2014 to 2026

    • Figure North America CRISPR/Cas9 Consumption Share by Types in 2014

    • Figure North America CRISPR/Cas9 Consumption Share by Types in 2018

    • Figure North America CRISPR/Cas9 Consumption Share by Types in 2026

    • Table North America CRISPR/Cas9 Consumption by End-Users from 2014 to 2026

    • Table North America CRISPR/Cas9 Consumption Share by End-Users from 2014 to 2026

    • Figure North America CRISPR/Cas9 Consumption Share by End-Users in 2014

    • Figure North America CRISPR/Cas9 Consumption Share by End-Users in 2018

    • Figure North America CRISPR/Cas9 Consumption Share by End-Users in 2026

    • Table North America CRISPR/Cas9 Consumption by Major Countries from 2014 to 2026

    • Table North America CRISPR/Cas9 Consumption Share by Major Countries from 2014 to 2026

    • Figure North America CRISPR/Cas9 Consumption Share by Major Countries in 2014

    • Figure North America CRISPR/Cas9 Consumption Share by Major Countries in 2018

    • Figure North America CRISPR/Cas9 Consumption Share by Major Countries in 2026

    • Figure United States CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Table Europe CRISPR/Cas9 Consumption by Types from 2014 to 2026

    • Table Europe CRISPR/Cas9 Consumption Share by Types from 2014 to 2026

    • Figure Europe CRISPR/Cas9 Consumption Share by Types in 2014

    • Figure Europe CRISPR/Cas9 Consumption Share by Types in 2018

    • Figure Europe CRISPR/Cas9 Consumption Share by Types in 2026

    • Table Europe CRISPR/Cas9 Consumption by End-Users from 2014 to 2026

    • Table Europe CRISPR/Cas9 Consumption Share by End-Users from 2014 to 2026

    • Figure Europe CRISPR/Cas9 Consumption Share by End-Users in 2014

    • Figure Europe CRISPR/Cas9 Consumption Share by End-Users in 2018

    • Figure Europe CRISPR/Cas9 Consumption Share by End-Users in 2026

    • Table Europe CRISPR/Cas9 Consumption by Major Countries from 2014 to 2026

    • Table Europe CRISPR/Cas9 Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe CRISPR/Cas9 Consumption Share by Major Countries in 2014

    • Figure Europe CRISPR/Cas9 Consumption Share by Major Countries in 2018

    • Figure Europe CRISPR/Cas9 Consumption Share by Major Countries in 2026

    • Figure Germany CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure UK CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure France CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific CRISPR/Cas9 Consumption by Types from 2014 to 2026

    • Table Asia Pacific CRISPR/Cas9 Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific CRISPR/Cas9 Consumption Share by Types in 2014

    • Figure Asia Pacific CRISPR/Cas9 Consumption Share by Types in 2018

    • Figure Asia Pacific CRISPR/Cas9 Consumption Share by Types in 2026

    • Table Asia Pacific CRISPR/Cas9 Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific CRISPR/Cas9 Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific CRISPR/Cas9 Consumption Share by End-Users in 2014

    • Figure Asia Pacific CRISPR/Cas9 Consumption Share by End-Users in 2018

    • Figure Asia Pacific CRISPR/Cas9 Consumption Share by End-Users in 2026

    • Table Asia Pacific CRISPR/Cas9 Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific CRISPR/Cas9 Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific CRISPR/Cas9 Consumption Share by Major Countries in 2014

    • Figure Asia Pacific CRISPR/Cas9 Consumption Share by Major Countries in 2018

    • Figure Asia Pacific CRISPR/Cas9 Consumption Share by Major Countries in 2026

    • Figure China CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandCRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure India CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa CRISPR/Cas9 Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa CRISPR/Cas9 Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa CRISPR/Cas9 Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa CRISPR/Cas9 Consumption Share by Major Countries in 2026

    • Figure GCC Countries CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina CRISPR/Cas9 Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Caribou Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Caribou Biosciences

    • Figure Sales and Growth Rate Analysis of Caribou Biosciences

    • Figure Revenue and Market Share Analysis of Caribou Biosciences

    • Table Product and Service Introduction of Caribou Biosciences

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Synthego

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthego

    • Figure Sales and Growth Rate Analysis of Synthego

    • Figure Revenue and Market Share Analysis of Synthego

    • Table Product and Service Introduction of Synthego

    • Table Company Profile and Development Status of Cellecta

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellecta

    • Figure Sales and Growth Rate Analysis of Cellecta

    • Figure Revenue and Market Share Analysis of Cellecta

    • Table Product and Service Introduction of Cellecta

    • Table Company Profile and Development Status of Mirus Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mirus Bio

    • Figure Sales and Growth Rate Analysis of Mirus Bio

    • Figure Revenue and Market Share Analysis of Mirus Bio

    • Table Product and Service Introduction of Mirus Bio

    • Table Company Profile and Development Status of CRISPR Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CRISPR Therapeutics

    • Figure Sales and Growth Rate Analysis of CRISPR Therapeutics

    • Figure Revenue and Market Share Analysis of CRISPR Therapeutics

    • Table Product and Service Introduction of CRISPR Therapeutics

    • Table Company Profile and Development Status of GenScript

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GenScript

    • Figure Sales and Growth Rate Analysis of GenScript

    • Figure Revenue and Market Share Analysis of GenScript

    • Table Product and Service Introduction of GenScript

    • Table Company Profile and Development Status of Takara Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takara Bio

    • Figure Sales and Growth Rate Analysis of Takara Bio

    • Figure Revenue and Market Share Analysis of Takara Bio

    • Table Product and Service Introduction of Takara Bio

    • Table Company Profile and Development Status of GeneCopoeia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GeneCopoeia

    • Figure Sales and Growth Rate Analysis of GeneCopoeia

    • Figure Revenue and Market Share Analysis of GeneCopoeia

    • Table Product and Service Introduction of GeneCopoeia

    • Table Company Profile and Development Status of Intellia Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intellia Therapeutics

    • Figure Sales and Growth Rate Analysis of Intellia Therapeutics

    • Figure Revenue and Market Share Analysis of Intellia Therapeutics

    • Table Product and Service Introduction of Intellia Therapeutics

    • Table Company Profile and Development Status of Horizon Discovery Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Horizon Discovery Group

    • Figure Sales and Growth Rate Analysis of Horizon Discovery Group

    • Figure Revenue and Market Share Analysis of Horizon Discovery Group

    • Table Product and Service Introduction of Horizon Discovery Group

    • Table Company Profile and Development Status of Agilent Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies

    • Figure Sales and Growth Rate Analysis of Agilent Technologies

    • Figure Revenue and Market Share Analysis of Agilent Technologies

    • Table Product and Service Introduction of Agilent Technologies

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of Editas Medicine

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Editas Medicine

    • Figure Sales and Growth Rate Analysis of Editas Medicine

    • Figure Revenue and Market Share Analysis of Editas Medicine

    • Table Product and Service Introduction of Editas Medicine

    • Table Company Profile and Development Status of Integrated DNA Technologies (IDT)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Integrated DNA Technologies (IDT)

    • Figure Sales and Growth Rate Analysis of Integrated DNA Technologies (IDT)

    • Figure Revenue and Market Share Analysis of Integrated DNA Technologies (IDT)

    • Table Product and Service Introduction of Integrated DNA Technologies (IDT)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US